Danish Software Stock News

CPSE:SCHO
CPSE:SCHOFood

Schouw Shareholders Alter Bond Guarantees As BioMar Role Scales Back

Aktieselskabet Schouw & Co. (CPSE:SCHO) shareholders approved the release of BioMar as an Original Guarantor under the company’s bond terms. The decision removes BioMar from its status as a Material Subsidiary in the bond documentation. The approval was granted by a majority vote of shareholders. Aktieselskabet Schouw & Co. (CPSE:SCHO) is a Danish industrial group with holdings across several sectors, and BioMar has been one of its key subsidiaries. The shareholder-backed decision to remove...
CPSE:AMBU B
CPSE:AMBU BMedical Equipment

February 2026's European Stocks Estimated To Be Below Fair Market Value

As European markets remain buoyant, with the STOXX Europe 600 Index reaching new highs and optimism about the eurozone economy prevailing, investors are keenly observing potential opportunities amid recent market volatility. In this context, identifying stocks that may be undervalued relative to their intrinsic worth can be a strategic approach for those looking to capitalize on market conditions where cyclical and value-oriented segments are gaining traction.
CPSE:SJF
CPSE:SJFBanks

Discovering Europe's Hidden Stock Gems In February 2026

As the pan-European STOXX Europe 600 Index reaches new highs, optimism about the eurozone economy is helping to counterbalance recent market volatility. With inflation slowing faster than forecast and key interest rates remaining steady, investors are increasingly focusing on small-cap stocks that may offer unique opportunities in this evolving landscape. Identifying promising stocks often involves looking for companies with strong fundamentals and potential growth catalysts that align well...
CPSE:COLO B
CPSE:COLO BMedical Equipment

Coloplast (CPSE:COLO B) Margin Compression Challenges Premium Profitability Narrative In Q1 2026

Coloplast Q1 2026 Earnings Snapshot Coloplast (CPSE:COLO B) opened its 2026 financial year with Q1 revenue of DKK 7.0b and basic EPS of DKK 6.21, alongside trailing twelve month EPS of DKK 17.70 and net income of DKK 4.0b. Over recent quarters the company has seen quarterly revenue move in a tight band between DKK 6.9b and DKK 7.0b, while quarterly EPS has ranged from DKK 3.57 to DKK 6.21 as net income shifted between DKK 805m and DKK 1.40b. This sets up this report as a check-in on how much...
CPSE:ORSTED
CPSE:ORSTEDRenewable Energy

Ørsted (CPSE:ORSTED) Returns To Profitability As High P/E Tests Bullish Narratives

Ørsted (CPSE:ORSTED) closed out FY 2025 with Q4 revenue of DKK23.1b and a basic EPS loss of DKK1.77, while trailing twelve month EPS sat at DKK1.95 on revenue of DKK73.2b. Over recent periods the company has seen quarterly revenue range from DKK12.3b to DKK23.1b and EPS swing from a profit of DKK10.57 in Q1 2025 to losses in Q3 and Q4. Investors are watching how consistently that full year profitability holds up. With trailing net income of DKK1.7b against those sizable top line figures, the...
CPSE:DANSKE
CPSE:DANSKEBanks

Danske Bank (CPSE:DANSKE) Margin Slippage Challenges Stable Nordic Bank Narrative

Danske Bank (CPSE:DANSKE) has wrapped up FY 2025 with fourth quarter revenue of DKK 15.2b and basic EPS of DKK 7.73, supported by trailing twelve month revenue of DKK 56.5b and EPS of DKK 27.94 that frame the latest print in a wider earnings run rate. That backdrop of steady headline revenue and EPS trends sets up a results season where the key question for you is how far the current profitability mix, including modestly softer margins, aligns with the rewards and risks already on your...